Amicus Therapeutics ApS — Credit Rating and Financial Key Figures

Amicus Therapeutics ApS (CVR number: 39359340) is a company from KØBENHAVN. The company recorded a gross profit of 1732.2 kDKK in 2023. The operating profit was 96.3 kDKK, while net earnings were 52.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 14.3 %, which can be considered good but Return on Equity (ROE) was 15.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 48.4 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Amicus Therapeutics ApS's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.